º»¹®¿µ¿ª
Main text area
eubiologics
history
2010
~
Now
- 2019
-
- 04Completion of the second plant (V Plant) in Chuncheon
- 2018
-
- 12Start of construction work for the second plant in Chuncheon
- 09Achievement of Euvichol-Plus¢ç 10 million doses exports
- 2017
-
- 12Technology Transfer Agreement of EcML (KIST)
- 08Euvichol-Plus¢ç prequalified (PQ) by WHO
- 01KOSDAQ Listed
- 2016
-
- 06Euvichol¢ç signed the Long Term Agreement (LTA) with UNICEF.
- 2015
-
- 12Euvichol¢ç prequalified (PQ) by WHO.
- 01Euvichol¢ç export approved by MFDS in Korea.
- 2014
-
- 09Additional API facilities for OCV (Euvichol¢ç) installed.
- 08Phase Three of clinical trial of OCV(Euvichol¢ç) succeeded in the Philippines.
- 2013
-
- 12IND approved for Phase Three of clinical trial of OCV(Euvichol¢ç) in the Philippines.
- 2012
-
- 07IND approved for Phase One of clinical trial of OCV(Euvichol¢ç) in Korea.
- 06Performed the technological development of the next-generation typhoid-fever vaccine (the Small and Medium Business Administration).
- 03 Merged with EuBiopharm Co., Ltd.
- 02Certified as a venture corporation.
- 2011
-
- 02Performed a non-clinical trial of OCV(Euvichol).
- 2010
-
- 12Performed the Tech. Transfer and a Feasibility Study.
- 09Signed the contract of technology transfer for Oral Cholera Vaccine (OCV) with the International Vaccine Institute (IVI).
- 03Founded EuBiologics Co., Ltd.